In BDL-induced cirrhosis, it acts, instead, through DDAH-2, an enzyme responsible for the degradation of asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of eNOS (41). The gene discussed is NOS3; the disease is Cirrhosis.